Geron (GERN) Total Liabilities (2010 - 2026)
Geron's (GERN) quarterly Total Liabilities came in at $305.0 million in Q1 2026, up 3.67% year-on-year from $294.2 million in Q1 2025, and down 11.51% quarter-over-quarter from $344.7 million in Q4 2025.
Geron (GERN) Total Liabilities (2010 - 2026) Analysis & Trends
Geron has disclosed Total Liabilities across 17 years of filings, most recently posting $305.0 million for Q1 2026.
- Total Liabilities for Q1 2026 came in at $305.0 million, up 3.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $305.0 million (up 3.67% YoY), and the FY2025 annual result was $344.7 million, up 9.96% from the prior year.
- Total Liabilities came in at $305.0 million for Q1 2026 at Geron, down from $344.7 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $344.7 million in Q4 2025 to a low of $96.1 million in Q2 2022.
- The 5-year median for Total Liabilities is $142.7 million (2024), against an average of $189.4 million.
- Across the five-year window, Total Liabilities decreased 2.09% in 2023 and surged 114.51% in 2024, its largest moves.
- Geron's Total Liabilities stood at $110.6 million in 2022, then soared by 32.15% to $146.1 million in 2023, then soared by 114.51% to $313.5 million in 2024, then increased by 9.96% to $344.7 million in 2025, then retreated by 11.51% to $305.0 million in 2026.
- The last three Total Liabilities figures came in at $305.0 million (Q1 2026), $344.7 million (Q4 2025), and $318.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 137.56 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 305.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305.01 Mn |
| Dec 31, 2025 | 344.67 Mn |
| Sep 30, 2025 | 318.68 Mn |
| Jun 30, 2025 | 295.67 Mn |
| Mar 31, 2025 | 294.21 Mn |
| Dec 31, 2024 | 313.46 Mn |
| Sep 30, 2024 | 152.67 Mn |
| Jun 30, 2024 | 142.70 Mn |
| Mar 31, 2024 | 137.21 Mn |
| Dec 31, 2023 | 146.13 Mn |
| Sep 30, 2023 | 122.40 Mn |
| Jun 30, 2023 | 116.87 Mn |
| Mar 31, 2023 | 98.82 Mn |
| Dec 31, 2022 | 110.58 Mn |
| Sep 30, 2022 | 124.43 Mn |
| Jun 30, 2022 | 96.11 Mn |
| Mar 31, 2022 | 100.93 Mn |
| Dec 31, 2021 | 99.62 Mn |
| Sep 30, 2021 | 77.54 Mn |
| Jun 30, 2021 | 75.97 Mn |